Respiratory Tract Diseases clinical trials
The registry lists 410 studies for Respiratory Tract Diseases across more than 10 countries. 59 are recruiting or about to start. 45 of them are mainly about Respiratory Tract Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 146 narrower conditions too, such as COVID-19: 54,719 studies, 9,531 open.
Get an email when these change. Save the Respiratory Tract Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
AstraZeneca (29) · National Center for Research Resources (NCRR) (22) · Medicago (12) · Pfizer (8) · FDA Office of Orphan Products Development (7) · Revolution Medicines, Inc. (6) · Aeris Therapeutics (5) · United Therapeutics (5)
What is being tested here
Drugs under test in Respiratory Tract Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| BNT162 Vaccine | 2 | 2 | 3 |
| SC1011 | 1 | 1 | 3 |
| Elironrasib | 1 | 0 | 2 |
| Ralinepag | 1 | 2 | 2 |
| Rentosertib | 1 | 0 | 2 |
| Tocilizumab | 1 | 1 | 2 |
| Hydroxychloroquine | 1 | 2 | 2 |
| Rivaroxaban | 1 | 0 | 2 |
| Imatinib | 1 | 2 | 2 |
| Nirmatrelvir | 1 | 1 | 2 |
Drug classes tested here Tyrosine kinase inhibitors (TKIs) 4 open · Immune checkpoint inhibitors 1 open · Corticosteroids 8 · Antimetabolites 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension · Phase 3 · United Therapeutics
- Dec 2026Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC) · Phase 3 · Qilu Pharmaceutical Co., Ltd.
- Dec 2026SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) · Phase 3 · Guangzhou JOYO Pharma Co., Ltd
- Apr 2027A Study of COVID-19 Vaccine(s) in Children and Adults · Phase 3 · BioNTech SE
- Sep 2027A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD) · Phase 3 · Grifols Therapeutics LLC
- Sep 2027Shortened Regimen for Drug-susceptible TB in Children · Phase 3 · Johns Hopkins University
- Oct 2027A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
- Nov 2027A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer · Phase 3 · Eli Lilly and Company
- Nov 2026BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS · Hospital Alemão Oswaldo Cruz
- Nov 2026The BEGIN Study Bifidobacterium Infantis to Newborns: Effects of Modulating the Gut Microbial Composition on Growth, Immune Function and Inflammatory Conditions - a Randomized Placebo-controlled Double-blinded Intervention Trial · University of Aarhus
Who these studies take
Of the 47 Respiratory Tract Diseases studies recruiting now, 27 (57%) set no upper age limit and 13 (28%) stop at 75 or younger. 14 (30%) take children under 18. 1 (2%) are for women only and 0 (0%) for men only; 14 (30%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 9 (19%) | 9 (19%) |
| 18 | 37 (79%) | 36 (77%) |
| 30 | 35 (74%) | 34 (72%) |
| 40 | 40 (85%) | 39 (83%) |
| 50 | 41 (87%) | 40 (85%) |
| 65 | 40 (85%) | 40 (85%) |
| 75 | 37 (79%) | 37 (79%) |
| 85 | 30 (64%) | 30 (64%) |
Across all 410 studies, recruiting or not: 35% stop at 75 or younger and 26% at 65; 31% take children; 2% are for women only and <1% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Respiratory Tract Diseases studies take
Of 41 phase 3 interventional studies under Respiratory Tract Diseases, half reached primary completion within 27 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 16 mo6–38 · 18 studies | — | — |
| Phase 2 | 18 mo10–30 · 30 studies | — | — |
| Phase 3 | 27 mo9–47 · 41 studies | 27 mo9–45 · 35 studies | — |
| Interventional, no phase | 30 mo11–74 · 52 studies | — | 34 mo11–74 · 46 studies |
| Observational | 35 mo12–65 · 37 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting1
Newly registered2
- An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)Nov 6, 2026NCT07923526
- Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)Nov 6, 2026NCT07923591
Studies
Recruiting first, then most recently updated. Showing 50 of 410. Browse all 410 → or search them.
- Collection of Lung Fluid and Tissue Samples for ResearchRecruitingNCT004712501 country
- Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD)RecruitingNCT06366113Not applicable1 country
- An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)Not yet recruitingNCT07923526Phase 2/31 country
- Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)Not yet recruitingNCT07923591Phase 21 country
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaRecruitingNCT06977581Phase 215 countries
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingNCT02735707Phase 329 countries
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerRecruitingNCT06119581Phase 329 countries
- A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)RecruitingNCT07555483Phase 39 countries
- Veterans Affairs Lung Cancer Surgery Or Stereotactic RadiotherapyRecruitingNCT02984761Not applicable1 country
- BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled AsthmaRecruitingNCT05341726Not applicable1 country
- A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)RecruitingNCT07431112Phase 19 countries
- Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe AsthmaRecruitingNCT07120503Phase 28 countries
- Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.RecruitingNCT07279935Phase 41 country
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruitingNCT06679140Phase 319 countries
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionEnrolling by invitationNCT03683186Phase 333 countries
- Impact of Pharmacist Led Multidisciplinary Deprescribing Strategy in Patients With Respiratory Tract InfectionsEnrolling by invitationNCT07849491Not applicable1 country
- A Study of COVID-19 Vaccine(s) in Children and AdultsRecruitingNCT07798648Phase 31 country
- Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsRecruitingNCT06128551Phase 1/27 countries
- Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in ChildrenEnrolling by invitationNCT06267859Early Phase 11 country
- Effectiveness of An Influenza/COVID-19 Vaccine (mCombriax [mRNA-1083]) in Adults ≥ 65 YearsNot yet recruitingNCT07790523Phase 42 countries
- The Effect of Using Virtual Reality Glasses and Gaming Cards on Fear, Anxiety, and Physiological Parameters in Children Administered Inhaler MedicationRecruitingNCT07780331Not applicable1 country
- Understanding New Cachexia Subtypes Through Observational Epidemiological ResearchRecruitingNCT077763531 country
- Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in HypotoniaRecruitingNCT05527652Not applicable1 country
- A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of AgeRecruitingNCT07730450Phase 41 country
- Shortened Regimen for Drug-susceptible TB in ChildrenRecruitingNCT06253715Phase 37 countries
- Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy AdultsRecruitingNCT06429930Phase 11 country
- Breathlessness Perceptions Within Respiratory DiseasesRecruitingNCT076480821 country
- Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)RecruitingNCT04179981Not applicable1 country
- Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After PneumoniaRecruitingNCT06602934Not applicable1 country
- A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsRecruitingNCT03093116Phase 1/219 countries
- BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDSRecruitingNCT071186831 country
- Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary EmbolismRecruitingNCT04263038Phase 45 countries
- Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and AdolescentsRecruitingNCT044618211 country
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable1 country
- Epidemiology and Current Practices in Severe Community-Acquired PneumoniaNot yet recruitingNCT073010991 country
- A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)RecruitingNCT06619561Phase 21 country
- TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for HispanicsRecruitingNCT07165691Not applicable1 country
- Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisRecruitingNCT05975983Phase 21 country
- AeviceMD for Detection of Wheeze in Pediatric and Adult PopulationsRecruitingNCT066919711 country
- Prospective Cohort of Integrated Traditional Chinese and Western Medicine in ChinaNot yet recruitingNCT07196917
- Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular DiseasesRecruitingNCT07090200Not applicable1 country
- Early Intervention Strategies for Lung CancerRecruitingNCT06988943Not applicable1 country
- AI in Respiratory Disease Prevention, Diagnosis, and TriageEnrolling by invitationNCT06931782Not applicable1 country
- Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort StudyRecruitingNCT067558401 country
- The Effect of Virtual Reality Goggles and Distraction Cards Applied to Children Aged 6-12 Years During Inhaler Therapy on Physiological Parameters and AnxietyNot yet recruitingNCT06893237Not applicable
- Impact of Educational Intervention Protocol on the Level of Knowledge, Clinical Control and Lung Function of People With AsthmaRecruitingNCT06878352Not applicable1 country
- The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of EmphysemaRecruitingNCT06655428Not applicable3 countries
- SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT06125327Phase 2/31 country
- The BEGIN Study Bifidobacterium Infantis to Newborns: Effects of Modulating the Gut Microbial Composition on Growth, Immune Function and Inflammatory Conditions - a Randomized Placebo-controlled Double-blinded Intervention TrialRecruitingNCT06452199Not applicable1 country
- MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS PatientsNot yet recruitingNCT06308926Phase 2